ArticleJournal of cardiology cases2025
Heart transplant in a patient with acute onset of heart failure and massive bi-ventricular thrombi: A case report.
Article in Journal of cardiology cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Massive biventricular thrombi are a rare but serious complication of acute heart failure with reduced ejection fraction, presenting significant challenges in management. These thrombi can cause coronary thrombi leading to hemodynamic instability and raise the risk of systemic embolism. A 42-year-old male with a past medical history of type 2 diabetes mellitus presented with cardiogenic shock and pulmonary embolism. He was found to have new onset of heart failure with left ventricular ejection fraction of 15 % and harboring large biventricular thrombi. Stress test showed over 50 % of his myocardium was infarcted. Due to these findings, after a multidisciplinary team discussion, he was placed on veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as bridge to orthotopic heart transplant (OHT), for hemodynamic support and prevention of distal embolization. He subsequently underwent OHT as an INTERMACS category 1 a few days later. This rare and complicated case highlights the importance of a multidisciplinary team approach, and utilization of VA-ECMO in an end-stage cardiomyopathy patient with large biventricular thrombi as bridge to OHT. Learning objective: Veno-arterial extracorporeal membrane oxygenation can be utilized to prevent systemic embolization as a bridge to orthotopic heart transplant in patients with biventricular thrombus and end-stage cardiomyopathy.Heart transplant can be a lifesaving treatment in a patient with biventricular thrombi and extensive non-viable myocardium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.